EUVIMEDEUVIMED entdecken
Open Access

Reduced TBX5 dosage undermines developmental control of atrial cardiomyocyte identity in a model of human atrial disease

Irfan S Kathiriya iD, Kavitha S Rao iD, Alexander P Clark iD, Kevin M Hu, Zoe L Grant iD, Megan N Matthews, Zhe Chen iD, Swetansu K Hota iD, Jeffrey J Saucerman iD, Benoit G Bruneau iD

Development · 2026

DOI: 10.1242/dev.205173 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Development, 2026. Verfasst von Irfan S Kathiriya und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesia and Perioperative Care, University of California, San Francisco, CA 94143, USA. Hauptthemen laut MEDLINE: T-Box Domain Proteins, Myocytes, Cardiac, Heart Atria, Atrial Fibrillation. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 109 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, Hellman Family Fund, American Heart Association.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

While atrial septal defects (ASDs) and atrial fibrillation (AF) present differently, there is evidence that they share some genetic basis. Here, we have used directed differentiation of human induced pluripotent stem cells into atrial or ventricular cardiomyocytes (CMs) to delineate gene regulatory networks (GRNs) that define each identity. We uncovered accessible chromatin regions, transcription factor motifs and key regulatory nodes specific to, or shared by, both CM types, including the transcription factor TBX5, which is linked to genetic susceptibility of ASDs and AF in humans. Complete TBX5 loss resulted in a near absence of atrial CMs, with a concomitant increase in the abundance of other cell types. Reduced dosage of TBX5 in human atrial CMs caused cellular, electrophysiological and molecular phenotypes consistent with features of atrial CM dysfunction. This included dose-dependent aberrant accessibility of many chromatin regions and perturbation of gene regulatory networks of atrial CM identity. These results suggest that, in addition to stemming from ion channel or extracellular matrix dysfunction, atrial diseases such as ASDs or AF may result from disruptions of atrial CM identity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

T-Box Domain ProteinsMyocytes, CardiacHeart AtriaAtrial FibrillationHeart Septal Defects, AtrialHumansCell DifferentiationInduced Pluripotent Stem CellsGene Regulatory NetworksChromatinGene Expression Regulation, Developmental

Stichwörter der Autor:innen

Atrial fibrillationAtrial septal defectsCardiomyocyte differentiationCongenital heart defectsDisease modelingHuman atrial diseases

Substanzen

T-Box Domain ProteinsT-box transcription factor 5Chromatin

Autor:innen und Institutionen

  • Department of Anesthesia and Perioperative Care, University of California, San Francisco, CA 94143, USA.
  • Gladstone Institutes, San Francisco, CA 94158, USA.
  • Department of Biomedical Engineering, University of Virginia, Charlottesville, VA 22908, USA.
  • Robert M. Berne Cardiovascular Research Center, University of Virginia, Charlottesville, VA 22908, USA.
  • Roddenberry Center for Stem Cell Biology and Medicine, Gladstone Institutes, San Francisco, CA 94158, USA.
  • Cardiovascular Research Institute, University of California, San Francisco, CA 94158, USA.

ORCID-Profile: Irfan S Kathiriya, Kavitha S Rao, Alexander P Clark, Zoe L Grant, Zhe Chen, Swetansu K Hota, Jeffrey J Saucerman, Benoit G Bruneau

Förderung

  • NHLBI NIH HHS
  • Hellman Family Fund
  • American Heart Association
  • The Roddenberry Foundation
  • Saving Tiny Hearts Society
  • Additional Ventures
  • NCRR NIH HHS
  • Younger Family Fund

Zitieren

APA

Kathiriya, I. S., Rao, K. S., Clark, A. P., Hu, K. M., Grant, Z. L., Matthews, M. N., Chen, Z., Hota, S. K., Saucerman, J. J., & Bruneau, B. G. (2026). Reduced TBX5 dosage undermines developmental control of atrial cardiomyocyte identity in a model of human atrial disease. Development. https://doi.org/10.1242/dev.205173

Vancouver

Kathiriya IS, Rao KS, Clark AP, Hu KM, Grant ZL, Matthews MN, et al. Reduced TBX5 dosage undermines developmental control of atrial cardiomyocyte identity in a model of human atrial disease. Development. 2026. doi:10.1242/dev.205173

BibTeX
@article{Kathiriya2026,
  author = {Kathiriya, Irfan S and Rao, Kavitha S and Clark, Alexander P and Hu, Kevin M and Grant, Zoe L and Matthews, Megan N and Chen, Zhe and Hota, Swetansu K and Saucerman, Jeffrey J and Bruneau, Benoit G},
  title = {Reduced TBX5 dosage undermines developmental control of atrial cardiomyocyte identity in a model of human atrial disease},
  journal = {Development},
  year = {2026},
  doi = {10.1242/dev.205173}
}
Kostenlos starten →